Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
G

GMED

NYSE

GLOBUS MEDICAL INC

Latest disclosureSeptember 16, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 3 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 14

Limited filing history
All14Buying0Selling3Other11
Filters

Last 30 daysNo qualifying insider buying. Sales: $2.24M by 1 insider.

11 of 14 trades · June 4, 2026 – September 15, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 11 trades on this page.

Exercise or conversion

James R. Tobin

Director

Class A Common Stock

Value context
$806.25K
Reported price
$53.75 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Exercise or conversion

James R. Tobin

Director

Class A Common Stock

Value context
$955.2K
Reported price
$63.68 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Exercise or conversion

James R. Tobin

Director

Stock Option (Right to Buy Class A Common Stock)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$53.75 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 15, 2026Filed September 16, 2026SEC filing
Exercise or conversion

James R. Tobin

Director

Stock Option (Right to Buy Class A Common Stock)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$63.68 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 15, 2026Filed September 16, 2026SEC filing
Exercise or conversion

Stephen T. Zarrilli

Director

Class A Common Stock

Value context
$1.33M
Reported price
$53.27 / share
Traded August 18, 2026Filed August 19, 2026SEC filing
Exercise or conversion

Stephen T. Zarrilli

Director

Stock Option (Right to Buy Class A Common Stock)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$53.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 18, 2026Filed August 19, 2026SEC filing
Gift disclosed

David D. Davidar

Director

Class A Common Stock

Value context
Not a purchase
Reported price
Gift · no purchase price
Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Traded July 27, 2026Filed July 28, 2026SEC filing
Exercise or conversion

David D. Davidar

Director

Class A Common Stock

Value context
$656.75K
Reported price
$26.27 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Exercise or conversion

David D. Davidar

Director

Stock Option (Right to Buy Class A Common Stock)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$26.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 5, 2026Filed June 9, 2026SEC filing
Exercise or conversion

Ann D. Rhoads

Director

Class A Common Stock

Value context
$656.75K
Reported price
$26.27 / share
Traded June 4, 2026Filed June 8, 2026SEC filing
Exercise or conversion

Ann D. Rhoads

Director

Stock Option (Right to Buy Class A Common Stock)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$26.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 4, 2026Filed June 8, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorClass A Common StockOption exercise or conversion15,000$53.75 / share$806.25KSep 15Filed Sep 16 · 1d laterSEC filing
DirectorClass A Common StockOption exercise or conversion15,000$63.68 / share$955.2KSep 15Filed Sep 16 · 1d laterSEC filing
DirectorStock Option (Right to Buy Class A Common Stock)Option exercise or conversionDerivative units15,000$53.75 exercise / conversion priceNot a separate purchaseSep 15Filed Sep 16 · 1d laterSEC filing
DirectorStock Option (Right to Buy Class A Common Stock)Option exercise or conversionDerivative units15,000$63.68 exercise / conversion priceNot a separate purchaseSep 15Filed Sep 16 · 1d laterSEC filing
DirectorClass A Common StockOption exercise or conversion25,000$53.27 / share$1.33MAug 18Filed Aug 19 · 1d laterSEC filing
DirectorStock Option (Right to Buy Class A Common Stock)Option exercise or conversionDerivative units25,000$53.27 exercise / conversion priceNot a separate purchaseAug 18Filed Aug 19 · 1d laterSEC filing
DirectorClass A Common StockGift2,500Gift · no purchase priceNot a purchaseJul 27Filed Jul 28 · 1d laterSEC filing
DirectorClass A Common StockOption exercise or conversion25,000$26.27 / share$656.75KJun 5Filed Jun 9 · 4d laterSEC filing
DirectorStock Option (Right to Buy Class A Common Stock)Option exercise or conversionDerivative units25,000$26.27 exercise / conversion priceNot a separate purchaseJun 5Filed Jun 9 · 4d laterSEC filing
DirectorClass A Common StockOption exercise or conversion25,000$26.27 / share$656.75KJun 4Filed Jun 8 · 4d laterSEC filing
DirectorStock Option (Right to Buy Class A Common Stock)Option exercise or conversionDerivative units25,000$26.27 exercise / conversion priceNot a separate purchaseJun 4Filed Jun 8 · 4d laterSEC filing

Congress transactions 2

All Congress filings
Purchase disclosed

Globus Medical, Inc. Class A Common Stock (GMED) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
August 19, 2026
Filed September 10, 2026 · 22d laterOriginal report
Purchase disclosed

Globus Medical, Inc. Class A Common Stock (GMED) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 3, 2026
Filed April 7, 2026 · 35d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001237831
Latest public acceptance
Sep 16, 2026, 08:35 PM UTC
Score calculated
Oct 8, 2026, 12:06 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.